- Home
- AVNT vs VCYT Comparison
AVNT vs VCYT Comparison
Compare AVNT & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVNT | VCYT |
|---|---|---|
| Founded | 1927 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.9B |
| IPO Year | 1993 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AVNT | VCYT |
|---|---|---|
| Price | $36.15 | $38.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $45.29 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 790.5K | 740.2K |
| Earning Date | 02-12-2026 | 02-23-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.23 | 0.38 |
| Revenue | ★ $3,246,100,000.00 | $495,141,000.00 |
| Revenue This Year | $2.24 | $16.46 |
| Revenue Next Year | $2.41 | $11.37 |
| P/E Ratio | ★ $29.83 | $104.62 |
| Revenue Growth | 1.03 | ★ 16.41 |
| 52 Week Low | $27.48 | $22.61 |
| 52 Week High | $44.78 | $50.71 |
Technical Indicators
Market Signals| Indicator | AVNT | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 65.03 | 36.99 |
| Support Level | $36.37 | $40.29 |
| Resistance Level | $37.77 | $45.55 |
| Average True Range (ATR) | 1.03 | 1.91 |
| MACD | 0.10 | -0.39 |
| Stochastic Oscillator | 74.38 | 6.94 |
Price Performance
Historical ComparisonAbout AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.